Let's talk medical research

Clinical trials are how researchers advance their knowledge about potential new treatments, including medications, medical devices, and lifestyle ...

Connecting patients with clinical research opportunities is our mission here at Antidote, but often, we find that misconceptions can serve as ...

Antidote’s podcast, Talk of the Towne, hosted by Antidote’s Senior Clinical Informatics Manager, Dr. Richard Towne, is an interview series featuring ...

Alzheimer’s disease, the most prevalent type of dementia, is diagnosed in more than 6 million Americans. Estimates project that by 2050, 13 million ...

Today, Antidote is excited to announce our collaboration with Beyond Type 1 and JDRF to release the first-ever Spanish-language clinical trial search ...

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It ...

Helping patients find out about clinical trials is one of the chief pillars of the work Antidote does, and one of the ways we do this is through our ...

Persistent corneal epithelial defects are more than just an eye injury. The corneal epithelium is an integral part of the eye, tasked with guarding ...

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done ...

IgA nephropathy, also known as IgAN or Berger disease, is a common kidney disease that can impact any individual at any age. It is one of the most ...